eXoZymes Inc. Common Stock EXOZ Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| $1.12M+95.0% | $1.11M+76.5% | $1.22M+68.2% | $802.99K+238% | $575.02K+107% | ||
| $1.27M-8.0% | $1.58M+17.0% | $1.31M+47.0% | $1.75M+59.9% | $1.38M+88.2% | ||
| $2.39M+22.4% | $2.7M+35.9% | $2.52M+56.5% | $2.55M+91.8% | $1.95M+93.4% | ||
| -$2.39M-22.4% | -$2.7M-35.9% | -$2.52M-56.5% | -$2.55M-91.8% | -$1.95M-93.4% | ||
| $13.72K-85.5% | $132.04K+4,048% | $59.19K+32.6% | $76.56K+357% | $94.31K+58.3% | ||
| $3.01K— | —— | $176.03K+10,403% | $111.2K+6,609% | —— | ||
| -$2.37M-27.7% | -$2.76M-50.2% | -$2.29M-38.1% | -$2.36M-73.8% | -$1.86M-84.1% | ||
| —— | -$26.3K— | -$26.3K— | -$26.3K-1,327% | -$26.3K— | ||
| -$2.37M-27.7% | -$2.66M-44.6% | -$2.29M-38.1% | -$2.36M-73.5% | -$1.86M-84.1% | ||
| -$0.28-27.3% | -$0.31-24.0% | -$0.270.0% | -$0.28-27.3% | -$0.22-37.5% | ||
| -$2.31M-23.0% | -$2.62M-36.9% | -$2.45M-58.8% | -$2.48M-96.4% | -$1.88M-98.8% | ||
| -$2.39M-22.4% | -$2.7M-35.9% | -$2.52M-56.5% | -$2.55M-91.8% | -$1.95M-93.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is eXoZymes Inc. Common Stock's revenue?
- eXoZymes Inc. Common Stock (EXOZ) generated $70.1K in revenue over the trailing twelve months.
- Is eXoZymes Inc. Common Stock profitable?
- eXoZymes Inc. Common Stock is not currently profitable: it reported a net loss of $9.7M over the trailing twelve months, a -2909.1% net margin.
- What is eXoZymes Inc. Common Stock's earnings per share?
- eXoZymes Inc. Common Stock's diluted EPS over the trailing twelve months is $-1.14.
- Where does eXoZymes Inc. Common Stock's income statement data come from?
- Every line is extracted from eXoZymes Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
